In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia.

Severe amiodarone induced pulmonary toxicity.

Lymphoid hyperplasia and eosinophilic pneumonia as histologic manifestations of amiodarone-induced lung toxicity.

Hypersensitivity pneumonitis associated with the use of temozolomide.

Nodular amiodarone lung disease.

Histiocytic lesions and proliferations in the lung.

An unintended consequence: fatal amiodarone pulmonary toxicity in an older woman.

Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone.

Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocytochemistry.

Amiodarone-induced pulmonary toxicity. Immunoallergologic tests and bronchoalveolar lavage phospholipid content.

CT-pathology correlation of amiodarone lung.

Amiodarone pulmonary toxicity: clinical and subclinical features.

Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity.

Lung disease caused by amiodarone, a new antiarrythmic agent.

Amiodarone pulmonary toxicity.